Celcuity Q4 2022 Earnings Report
Key Takeaways
Celcuity Inc. reported a net loss of $11.6 million, or $0.69 loss per share, for the fourth quarter of 2022, compared to a net loss of $6.8 million, or $0.45 loss per share, for the fourth quarter of 2021. The company's operating expenses were $11.6 million for the fourth quarter of 2022, compared to $6.3 million for the fourth quarter of 2021. At December 31, 2022, Celcuity had cash, cash equivalents and short-term investments of $168.6 million.
Dosed the first patient in Phase 3 VIKTORIA-1 trial of gedatolisib in advanced breast cancer.
Closed $100 million PIPE financing and a $20 million drawdown on term loan.
Financings are expected to provide capital to fund operations through 2025.
Total operating expenses were $11.6 million for the fourth quarter of 2022.